Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Pyridone 6
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/28/2021
Flumatinib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
CoV2-26
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
(5-Chloropyridin-3-yl) 1H-indole-4-carboxylate
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/28/2021
Kasugamycin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
GC376
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
COV2-2130
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022
N(4)-Hydroxycytidine
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
CoV2-06
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
5-(Acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021
mAb Beta-54
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb 253
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
S2H97
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Pyronaridine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
ACE2-GpA-RBC
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
RBD-Fc Vacc
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
SARS-CoV-2-IN-1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/09/2020
S2X259
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Aloxistatin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/27/2021
S2K146
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022